SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Franco Oscar H) "

Sökning: WFRF:(Franco Oscar H)

Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
111.
  • Wahl, Simone, et al. (författare)
  • Epigenome-wide association study of body mass index, and the adverse outcomes of adiposity
  • 2017
  • Ingår i: Nature. - NATURE PUBLISHING GROUP. - 0028-0836 .- 1476-4687. ; 541:7635, s. 81-
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Approximately 1.5 billion people worldwide are overweight or affected by obesity, and are at risk of developing type (2) diabetes, cardiovascular disease and related metabolic and inflammatory disturbances(1,2). Although the mechanisms linking adiposity to associated clinical conditions are poorly understood, recent studies suggest that adiposity may influence DNA methylation(3-6), a key regulator of gene expression and molecular phenotype(7). Here we use epigenome-wide association to show that body mass index (BMI; a key measure of adiposity) is associated with widespread changes in DNA methylation (187 genetic loci with P &lt; 1 x 10(-7), range P = 9.2 x 10(-8) to 6.0 x 10(-46); n = 10,261 samples). Genetic association analyses demonstrate that the alterations in DNA methylation are predominantly the consequence of adiposity, rather than the cause. We find that methylation loci are enriched for functional genomic features in multiple tissues (P &lt; 0.05), and show that sentinel methylation markers identify gene expression signatures at 38 loci (P &lt; 9.0 x 10(-6), range P = 5.5 x 10(-6) to 6.1 x 10(-35), n = 1,785 samples). The methylation loci identify genes involved in lipid and lipoprotein metabolism, substrate transport and inflammatory pathways. Finally, we show that the disturbances in DNA methylation predict future development of type 2 diabetes (relative risk per 1 standard deviation increase in methylation risk score: 2.3 (2.07-2.56); P = 1.1 x 10(-54)). Our results provide new insights into the biologic pathways influenced by adiposity, and may enable development of new strategies for prediction and prevention of type 2 diabetes and other adverse clinical consequences of obesity.</p>
  •  
112.
  • Willeit, Peter, et al. (författare)
  • Natriuretic peptides and integrated risk assessment for cardiovascular disease an individual-participant-data meta-analysis
  • 2016
  • Ingår i: The Lancet Diabetes and Endocrinology. - Elsevier. - 2213-8587 .- 2213-8595. ; 4:10, s. 840-849
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background: Guidelines for primary prevention of cardiovascular diseases focus on prediction of coronary heart disease and stroke. We assessed whether or not measurement of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) concentration could enable a more integrated approach than at present by predicting heart failure and enhancing coronary heart disease and stroke risk assessment. Methods: In this individual-participant-data meta-analysis, we generated and harmonised individual-participant data from relevant prospective studies via both de-novo NT-proBNP concentration measurement of stored samples and collection of data from studies identified through a systematic search of the literature (PubMed, Scientific Citation Index Expanded, and Embase) for articles published up to Sept 4, 2014, using search terms related to natriuretic peptide family members and the primary outcomes, with no language restrictions. We calculated risk ratios and measures of risk discrimination and reclassification across predicted 10 year risk categories (ie, &lt;5%, 5% to &lt;7.5%, and &gt;= 7.5%), adding assessment of NT-proBNP concentration to that of conventional risk factors (ie, age, sex, smoking status, systolic blood pressure, history of diabetes, and total and HDL cholesterol concentrations). Primary outcomes were the combination of coronary heart disease and stroke, and the combination of coronary heart disease, stroke, and heart failure. Findings: We recorded 5500 coronary heart disease, 4002 stroke, and 2212 heart failure outcomes among 95617 participants without a history of cardiovascular disease in 40 prospective studies. Risk ratios (for a comparison of the top third vs bottom third of NT-proBNP concentrations, adjusted for conventional risk factors) were 1.76 (95% CI 1.56-1.98) for the combination of coronary heart disease and stroke and 2.00 (1.77-2.26) for the combination of coronary heart disease, stroke, and heart failure. Addition of information about NT-proBNP concentration to a model containing conventional risk factors was associated with a C-index increase of 0.012 (0.010-0.014) and a net reclassification improvement of 0.027 (0.019-0.036) for the combination of coronary heart disease and stroke and a C-index increase of 0.019 (0.016-0.022) and a net reclassification improvement of 0.028 (0.019-0.038) for the combination of coronary heart disease, stroke, and heart failure. Interpretation: In people without baseline cardiovascular disease, NT-proBNP concentration assessment strongly predicted first-onset heart failure and augmented coronary heart disease and stroke prediction, suggesting that NT-proBNP concentration assessment could be used to integrate heart failure into cardiovascular disease primary prevention.</p>
  •  
113.
  • Willeit, Peter, et al. (författare)
  • Natriuretic peptides and integrated risk assessment for cardiovascular disease an individual-participant-data meta-analysis
  • 2016
  • Ingår i: The Lancet Diabetes and Endocrinology. - 2213-8587 .- 2213-8595. ; 4:10, s. 840-849
  • Tidskriftsartikel (refereegranskat)abstract
    • <p>Background Guidelines for primary prevention of cardiovascular diseases focus on prediction of coronary heart disease and stroke. We assessed whether or not measurement of N-terminal-pro-B-type natriuretic peptide (NT-proBNP) concentration could enable a more integrated approach than at present by predicting heart failure and enhancing coronary heart disease and stroke risk assessment. Methods In this individual-participant-data meta-analysis, we generated and harmonised individual-participant data from relevant prospective studies via both de-novo NT-proBNP concentration measurement of stored samples and collection of data from studies identified through a systematic search of the literature (PubMed, Scientific Citation Index Expanded, and Embase) for articles published up to Sept 4, 2014, using search terms related to natriuretic peptide family members and the primary outcomes, with no language restrictions. We calculated risk ratios and measures of risk discrimination and reclassification across predicted 10 year risk categories (ie, &lt;5%, 5% to &lt;7.5%, and &gt;= 7.5%), adding assessment of NT-proBNP concentration to that of conventional risk factors (ie, age, sex, smoking status, systolic blood pressure, history of diabetes, and total and HDL cholesterol concentrations). Primary outcomes were the combination of coronary heart disease and stroke, and the combination of coronary heart disease, stroke, and heart failure. Findings We recorded 5500 coronary heart disease, 4002 stroke, and 2212 heart failure outcomes among 95617 participants without a history of cardiovascular disease in 40 prospective studies. Risk ratios (for a comparison of the top third vs bottom third of NT-proBNP concentrations, adjusted for conventional risk factors) were 1.76 (95% CI 1.56-1.98) for the combination of coronary heart disease and stroke and 2.00 (1.77-2.26) for the combination of coronary heart disease, stroke, and heart failure. Addition of information about NT-proBNP concentration to a model containing conventional risk factors was associated with a C-index increase of 0.012 (0.010-0.014) and a net reclassification improvement of 0.027 (0.019-0.036) for the combination of coronary heart disease and stroke and a C-index increase of 0.019 (0.016-0.022) and a net reclassification improvement of 0.028 (0.019-0.038) for the combination of coronary heart disease, stroke, and heart failure. Interpretation In people without baseline cardiovascular disease, NT-proBNP concentration assessment strongly predicted first-onset heart failure and augmented coronary heart disease and stroke prediction, suggesting that NT-proBNP concentration assessment could be used to integrate heart failure into cardiovascular disease primary prevention. Copyright (C) 2016 The Author(s). Published by Elsevier Ltd</p>
  •  
Skapa referenser, mejla, bekava och länka
Åtkomst
fritt online (42)
Typ av publikation
tidskriftsartikel (113)
Typ av innehåll
refereegranskat (113)
Författare/redaktör
Franco, Oscar H (111)
Hofman, Albert (82)
Uitterlinden, Andre ... (70)
Gudnason, Vilmundur (55)
Psaty, Bruce M. (50)
Rotter, Jerome I. (50)
visa fler...
Lind, Lars, (49)
Liu, Yongmei (45)
Harris, Tamara B. (43)
Chasman, Daniel I., (42)
Peters, Annette (42)
Ridker, Paul M., (37)
Ikram, M. Arfan (36)
Hayward, Caroline (36)
Salomaa, Veikko (35)
Lehtimaki, Terho (35)
Langenberg, Claudia (34)
Teumer, Alexander (33)
Esko, Tonu (32)
Loos, Ruth J. F. (32)
Ingelsson, Erik (31)
Boerwinkle, Eric (31)
Tanaka, Toshiko (31)
Gieger, Christian (30)
Perola, Markus (30)
Raitakari, Olli T (29)
Wareham, Nicholas J (29)
Scott, Robert A (29)
Samani, Nilesh J. (29)
Cupples, L. Adrienne (29)
van der Harst, Pim (29)
Smith, Albert V. (28)
Feitosa, Mary F. (28)
Siscovick, David S. (28)
Zhang, Weihua (28)
Ferrucci, Luigi (27)
Van Duijn, Cornelia ... (27)
Cheng, Ching -Yu (26)
Orho-Melander, Marju ... (26)
Luan, Jian'an (26)
Morris, Andrew P. (26)
Metspalu, Andres (26)
Kanoni, Stavroula (26)
Trompet, Stella (25)
Amin, Najaf (25)
Launer, Lenore J. (25)
Deloukas, Panos (25)
Kahonen, Mika (25)
Ferrières, Jean (25)
Verweij, Niek (25)
visa färre...
Lärosäte
Uppsala universitet (39)
Lunds universitet (36)
Umeå universitet (32)
Karolinska Institutet (16)
Göteborgs universitet (12)
Stockholms universitet (3)
visa fler...
Linköpings universitet (1)
visa färre...
Språk
Engelska (113)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (109)
Naturvetenskap (5)
Teknik (1)

År

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy